Literature DB >> 32578264

Maintaining the validity of inference in small-sample stepped wedge cluster randomized trials with binary outcomes when using generalized estimating equations.

Whitney P Ford1, Philip M Westgate1.   

Abstract

Stepped wedge cluster trials are an increasingly popular alternative to traditional parallel cluster randomized trials. Such trials often utilize a small number of clusters and numerous time intervals, and these components must be considered when choosing an analysis method. A generalized linear mixed model containing a random intercept and fixed time and intervention covariates is the most common analysis approach. However, the sole use of a random intercept applies a constant intraclass correlation coefficient structure, which is an assumption that is likely to be violated given stepped wedge trials (SWTs) have multiple time intervals. Alternatively, generalized estimating equations (GEE) are robust to the misspecification of the working correlation structure, although it has been shown that small-sample adjustments to standard error estimates and the use of appropriate degrees of freedom are required to maintain the validity of inference when the number of clusters is small. In this article, we show, using an extensive simulation study based on a motivating example and a more general design, the use of GEE can maintain the validity of inference in small-sample SWTs with binary outcomes. Furthermore, we show which combinations of bias corrections to standard error estimates and degrees of freedom work best in terms of attaining nominal type I error rates.
© 2020 John Wiley & Sons, Ltd.

Keywords:  degrees of freedom; empirical standard error; generalized estimating equations; group randomized trials; test size

Mesh:

Year:  2020        PMID: 32578264     DOI: 10.1002/sim.8575

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  9 in total

1.  Power calculation for analyses of cross-sectional stepped-wedge cluster randomized trials with binary outcomes via generalized estimating equations.

Authors:  Linda J Harrison; Rui Wang
Journal:  Stat Med       Date:  2021-09-23       Impact factor: 2.373

Review 2.  Stepped Wedge Cluster Randomized Trials: A Methodological Overview.

Authors:  Fan Li; Rui Wang
Journal:  World Neurosurg       Date:  2022-05       Impact factor: 2.210

3.  Divergent confidence intervals among pre-specified analyses in the HiSTORIC stepped wedge trial: An exploratory post-hoc investigation.

Authors:  Richard A Parker; Catriona Keerie; Christopher J Weir; Atul Anand; Nicholas L Mills
Journal:  PLoS One       Date:  2022-07-01       Impact factor: 3.752

4.  Sample size considerations for stepped wedge designs with subclusters.

Authors:  Kendra Davis-Plourde; Monica Taljaard; Fan Li
Journal:  Biometrics       Date:  2021-10-31       Impact factor: 1.701

5.  Randomization-based inference for a marginal treatment effect in stepped wedge cluster randomized trials.

Authors:  Dustin J Rabideau; Rui Wang
Journal:  Stat Med       Date:  2021-05-21       Impact factor: 2.497

6.  Marginal modeling of cluster-period means and intraclass correlations in stepped wedge designs with binary outcomes.

Authors:  Fan Li; Hengshi Yu; Paul J Rathouz; Elizabeth L Turner; John S Preisser
Journal:  Biostatistics       Date:  2022-07-18       Impact factor: 5.279

7.  Sample size and power considerations for cluster randomized trials with count outcomes subject to right truncation.

Authors:  Fan Li; Guangyu Tong
Journal:  Biom J       Date:  2021-03-10       Impact factor: 1.715

8.  Impact of unequal cluster sizes for GEE analyses of stepped wedge cluster randomized trials with binary outcomes.

Authors:  Zibo Tian; John S Preisser; Denise Esserman; Elizabeth L Turner; Paul J Rathouz; Fan Li
Journal:  Biom J       Date:  2021-10-01       Impact factor: 1.715

9.  Response adaptive intervention allocation in stepped-wedge cluster randomized trials.

Authors:  Michael J Grayling; James M S Wason; Sofía S Villar
Journal:  Stat Med       Date:  2022-01-21       Impact factor: 2.497

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.